Craniomaxillofacial Implants Market (Location: Internal and External Fixators; Composition: Calcium Ceramics, Metals and Alloys, Polymers, and Biologic Materials; Nature: Non-resorbable and Resorbable Fixators; Type: Plate and Screw Fixator Systems, Bone Graft Substitutes, Distraction Systems, and TMJ Replacement Devices) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2022


#291572

173pages

Transparency Market Research

$ 5795

In Stock

 

This report on the craniomaxillofacial implants market studies the current and future prospects of the global market. Craniomaxillofacial implants are rapidly gaining popularity in the global market due to increasing facial deformities and dislocations and growing awareness regarding the availability of technologically advanced implants. A variety of craniomaxillofacial implants are used to treat facial traumas, including metallic and non-metallic fixators. This report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments and sub-segments of the craniomaxillofacial implants market. It also provides information and data analysis of the global craniomaxillofacial implants market with respect to market segments based on the type of location, composition, nature, type, and their geographic markets. 

 

Based on location, the craniomaxillofacial implants market has been segmented into two major categories: internal and external fixators. Based on composition, the market has been categorized into four segments: calcium ceramics, metals and alloys, polymers, and biologic materials. Furthermore, based on nature, the craniomaxillofacial implants market has been segmented into non-resorbable and resorbable fixators. The craniomaxillofacial implants market has also been segmented based on product type that includes plate and screw fixator systems, bone graft substitutes, distraction systems, and TMJ replacement devices. The market segments have been extensively analyzed based on usefulness, efficacy, revenue, and geographical coverage. The market size and forecast in terms of USD million for each segment has been provided for the period from 2012 to 2022. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2014 to 2022, considering 2013 as the base year.

 

Geographically, the craniomaxillofacial implants market has been categorized into six major regions: North America, Europe, Asia Pacific, Latin America, Middle East and North Africa (MENA), and Rest of the World (RoW). The market size and forecast for each of these regions has been provided for the period from 2012 to 2022, along with their respective CAGRs for the forecast period from 2014 to 2022, considering 2013 as the base year. The research study also covers the competitive scenario in these regions. A detailed qualitative analysis of factors responsible for driving and restraining the growth of the market and future opportunities has been provided in the market overview section. This section of the report also provides market attractiveness analysis, value chain analysis, Porter’s Five Forces Analysis, and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global craniomaxillofacial implants market.

 

A list of recommendations has been provided for new entrants as well as existing market players to assist them in taking strategic initiatives to establish a strong presence in the market. The report also profiles major players in the craniomaxillofacial implants market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major players profiled in this report include DePuy Synthes, Stryker Corporation, Biomet, Inc., KLS Martin LP, OsteoMed, Anatomics Pty. Ltd., BIOPORE Surgical Implants, Calavera Surgical, ELLA-CS, s.r.o., Matrix Surgical USA, Medical Vision Australia Holdings, Poriferous, LLC, General Implants GmbH, GPC Medical Ltd., INION, INC., Narang Medical Limited, Ningbo Cibei Medical Treatment Appliance Co., Ltd., NRV OrthoTech Pvt. Ltd, O & M Medical GmbH, Ortho Max Manufacturing Company Pvt. Ltd., Osteotec Ltd., Rebstock Instruments GmbH, S.H. Pitkar Orthotools Pvt. Ltd., Shenzhen World Surgery Medical Device Technology Co., Ltd., B. Braun Melsungen AG, Boston Medical Products, Inc., Cavendish Implants Ltd., CONMED, Integra LifeSciences Holdings Corporation, Medartis AG, and Medtronic, Inc.

 

The global craniomaxillofacial implants market has been segmented as follows:

 

Craniomaxillofacial Implants Market, by Location

  • Internal Fixators
  • External Fixators

 

Craniomaxillofacial Implants Market, by Composition

  • Calcium Ceramics
  • Metals and Alloys
  • Polymers
  • Biologic Materials

 

Craniomaxillofacial Implants Market, by Nature

  • Non-resorbable
  • Resorbable Fixators

 

Craniomaxillofacial Implants Market, by Type

  • Plate and Screw Fixator System
  • Bone Graft Substitutes
  • Distraction Systems
  • TMJ Replacement Devices

 

Craniomaxillofacial Implants Market, by Geography

  • North America
  • Europe
  • Asia Pacific
  • Latin America (LATAM)
  • Middle East and North Africa (MENA)
  • Rest of the World (RoW)

 

Chapter 1 Introduction

1.1 Report Description

1.2 Market Segmentation

1.3 Research Methodology

 

Chapter 2 Executive Summary

2.1 Market Snapshot: Global Craniomaxillofacial Implants Market

2.2 Comparative Analysis: Global Craniomaxillofacial Implants Market Revenue, by Geography, 2013 and 2022 (Value %)

 

Chapter 3 Global Craniomaxillofacial Implants Market Overview

3.1 Introduction

3.2 Market Drivers

3.2.1 Constant rise in incidence of facial fractures

3.2.2 Emergence of new technological advancements and minimally invasive techniques in the field of trauma fixation

3.2.3 Increased health care expenditure globally

3.3 Market Restraints

3.3.1 High cost of craniomaxillofacial surgery

3.3.2 Absence of health insurance schemes in developing countries

3.4 Market Opportunities

3.4.1 Shift from metallic to nonmetallic (bioresorbable) material for internal fixators

3.4.2 Emerging economies to offer sustained growth opportunities

3.5 Porter’s Five Forces Analysis: Global Craniomaxillofacial Implants Market

3.5.1 Bargaining Power of Suppliers

3.5.2 Bargaining Power of Buyers

3.5.3 Threat of Substitutes

3.5.4 Threat of New Entrants

3.5.5 Competitive Rivalry

3.6 Regulatory Framework: Global Craniomaxillofacial Implants Market

3.7 Value Chain Analysis: Global Craniomaxillofacial Implants Market

3.8 Market Attractiveness Analysis: Global Craniomaxillofacial Implants Market, by Geography

3.9 Competitive Landscape

3.9.1 Market Share by Key Players of the Global Craniomaxillofacial Implants Market, 2013 (%)

 

Chapter 4 Global Craniomaxillofacial Implants Market, by Location

4.1 Overview

4.1.1 Global Craniomaxillofacial Implants Market Revenue, by Location, 2012 – 2022 (USD Million)

4.2 Internal Fixators

4.2.1 Global Internal Fixators of Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

4.3 External Fixators

4.3.1 Global External Fixators of Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

 

Chapter 5 Global Craniomaxillofacial Implants Market, by Composition

5.1 Overview

5.1.1 Global Craniomaxillofacial Implants Market Revenue, by Composition, 2012 – 2022 (USD Million)

5.1.2 Comparative Analysis: Global Craniomaxillofacial Implants Market, by Composition, 2013 and 2022 (Value %)

5.2 Calcium Ceramics

5.2.1 Global Calcium Ceramics Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

5.3 Metals and Alloys

5.3.1 Global Metals and Alloys Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

5.4 Polymers

5.4.1 Global Polymers Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

5.5 Biologic Materials

5.5.1 Global Biologic Materials Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

 

Chapter 6 Global Craniomaxillofacial Implants Market, by Nature

6.1 Overview

6.1.1 Global Craniomaxillofacial Implants Market Revenue, by Nature, 2012 – 2022 (USD Million)

6.2 Non-resorbable Fixators

6.2.1 Global Non-resorbable Fixators in Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

6.3 Resorbable Fixators

6.3.1 Global Resorbable Fixators in Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

 

Chapter 7 Global Craniomaxillofacial Implants Market, by Product

7.1 Overview

7.1.1 Global Craniomaxillofacial Implants Market Revenue, by Product, 2012 – 2022 (USD Million)

7.1.2 Comparative Analysis: Global Craniomaxillofacial Implants Market, by Type, 2013 and 2022 (Value %)

7.2 Plate and Screw Fixator Systems

7.2.1 Global Plate and Screw Fixator Systems in Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

7.3 Bone Graft Substitutes

7.3.1 Global Bone Graft Substitutes in Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

7.4 Distraction Systems

7.4.1 Global Distraction Systems in Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

7.5 Temporomandibular Joint (TMJ) Replacement Devices

7.5.1 Global TMJ Replacement Devices in Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

 

Chapter 8 Global Craniomaxillofacial Implants Market, by Geography

8.1 Overview

8.1.1 Global Craniomaxillofacial Implants Market Revenue, by Geography, 2012 – 2022 (USD Million)

8.2 North America

8.2.1 North America Craniomaxillofacial Implants Market Revenue, by Country, 2012 – 2022 (USD Million)

8.2.2 U.S. Craniomaxillofacial Implants Market Revenue, 2012 - 2022 (USD Million)

8.2.3 Canada Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

8.3 Europe

8.3.1 Europe Craniomaxillofacial Implants Market Revenue, by Country, 2012 – 2022 (USD Million)

8.3.2 U.K. Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

8.3.3 Germany Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

8.3.4 France Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

8.3.5 Rest of Europe Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

8.4 Asia Pacific

8.4.1 Asia Pacific Craniomaxillofacial Implants Market Revenue, by Country, 2012 – 2022 (USD Million)

8.4.2 Japan Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

8.4.3 China Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

8.4.4 Rest of Asia Pacific Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

8.5 Latin America

8.5.1 Latin America Craniomaxillofacial Implants Market Revenue, by Country, 2012 – 2022 (USD Million)

8.5.2 Brazil Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

8.5.3 Rest of Latin America Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

8.6 MENA

8.6.1 MENA Craniomaxillofacial Implants Market Revenue, by Country, 2012 – 2022 (USD Million)

8.6.2 UAE Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

8.6.3 Rest of MENA Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

8.7 Rest of the World (RoW)

8.7.1 Rest of the World Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

 

Chapter 9 Recommendations

 

Chapter 10 Company Profiles

10.1 Anatomics Pty Ltd

10.1.1 Company Overview

10.1.2 Financial Overview

10.1.3 Product Portfolio

10.1.4 Business Strategies

10.1.5 Recent Developments

10.2 B. Braun Melsungen AG

10.2.1 Company Overview

10.2.2 Financial Overview

10.2.3 Product Portfolio

10.2.4 Business Strategy

10.2.5 Recent Developments

10.3 Biomet, Inc.

10.3.1 Company Overview

10.3.2 Financial Overview

10.3.3 Product Portfolio

10.3.4 Business Strategies

10.3.5 Recent Developments

10.4 BIOPORE Surgicals

10.4.1 Company Overview

10.4.2 Financial Overview

10.4.3 Product Portfolio

10.4.4 Business Strategies

10.5 Boston Medical Products, Inc.

10.5.1 Company Overview

10.5.2 Financial Overview

10.5.3 Product Portfolio

10.5.4 Business Strategies

10.5.5 Recent Developments

10.6 Calavera Surgical Design, Inc.

10.6.1 Company Overview

10.6.2 Financial Overview

10.6.3 Product Portfolio

10.6.4 Business Strategies

10.6.5 Recent Developments

10.7 Cavendish Implants Ltd.

10.7.1 Company Overview

10.7.2 Financial Overview

10.7.3 Product Portfolio

10.7.4 Business Strategies

10.7.5 Recent Developments

10.8 CONMED Corporation

10.8.1 Company Overview

10.8.2 Financial Overview

10.8.3 Product Portfolio

10.8.4 Business Strategies

10.8.5 Recent Developments

10.9 DePuySynthes, Inc. (a J & J Company)

10.9.1 Company Overview

10.9.2 Financial Overview

10.9.3 Product Portfolio

10.9.4 Business Strategies

10.9.5 Recent Developments

10.10 ELLA-CS, s.r.o.

10.10.1 Company Overview

10.10.2 Financial Overview

10.10.3 Product Portfolio

10.10.4 Business Strategies

10.10.5 Recent Developments

10.11 General Implants GmbH

10.11.1 Company Overview

10.11.2 Financial Overview

10.11.3 Product Portfolio

10.11.4 Business Strategies

10.11.5 Recent Developments

10.12 GPC Medical Limited

10.12.1 Company Overview

10.12.2 Financial Overview

10.12.3 Product Portfolio

10.12.4 Business Strategies

10.12.5 Recent Developments

10.13 Integra LifeSciences Corporation

10.13.1 Company Overview

10.13.2 Financial Overview

10.13.3 Product Portfolio

10.13.4 Business Strategies

10.13.5 Recent Developments

10.14 KLS Martin LP

10.14.1 Company Overview

10.14.2 Financial Overview

10.14.3 Product Portfolio

10.14.4 Business Strategies

10.14.5 Recent Developments

10.15 Matrix Surgical USA

10.15.1 Company Overview

10.15.2 Financial Overview

10.15.3 Product Portfolio

10.15.4 Business Strategies

10.15.5 Recent Developments

10.16 Medartis AG

10.16.1 Company Overview

10.16.2 Financial Overview

10.16.3 Product Portfolio

10.16.4 Business Strategies

10.16.5 Recent Developments

10.17 Medical Vision Australia Holdings

10.17.1 Company Overview

10.17.2 Financial Overview

10.17.3 Product Portfolio

10.17.4 Business Strategies

10.17.5 Recent Developments

10.18 Medtronic, Inc.

10.18.1 Company Overview

10.18.2 Financial Overview

10.18.3 Product Portfolio

10.18.4 Business Strategies

10.18.5 Recent Developments

10.19 Narang Medical Limited

10.19.1 Company Overview

10.19.2 Financial Overview

10.19.3 Product Portfolio

10.19.4 Business Strategies

10.19.5 Recent Developments

10.20 Naton Medical Group

10.20.1 Company Overview

10.20.2 Financial Overview

10.20.3 Product Portfolio

10.20.4 Business Strategies

10.20.5 Recent Developments

10.21 Ningbo Cibei Medical Treatment Appliance Co. Ltd.

10.21.1 Company Overview

10.21.2 Financial Overview

10.21.3 Product Portfolio

10.21.4 Business Strategies

10.22 NRV OrthoTech Pvt Ltd

10.22.1 Company Overview

10.22.2 Financial Overview

10.22.3 Product Portfolio

10.22.4 Business Strategies

10.22.5 Recent Developments

10.23 O & M Medical GmbH

10.23.1 Company Overview

10.23.2 Financial Overview

10.23.3 Product Portfolio

10.23.4 Business Strategies

10.23.5 Recent Developments

10.24 Ortho Max Manufacturing Company Pvt. Ltd.

10.24.1 Company Overview

10.24.2 Financial Overview

10.24.3 Product Portfolio

10.24.4 Business Strategies

10.24.5 Recent Developments

10.25 OsteoMed

10.25.1 Company Overview

10.25.2 Financial Overview

10.25.3 Product Portfolio

10.25.4 Business Strategies

10.25.5 Recent Developments

10.26 Osteotec Ltd

10.26.1 Company Overview

10.26.2 Financial Overview

10.26.3 Product Portfolio

10.26.4 Business Strategies

10.26.5 Recent Developments

10.27 Poriferous, LLC

10.27.1 Company Overview

10.27.2 Financial Overview

10.27.3 Product Portfolio

10.27.4 Business Strategies

10.27.5 Recent Developments

10.28 Rebstock Instruments GmbH

10.28.1 Company Overview

10.28.2 Financial Overview

10.28.3 Product Portfolio

10.28.4 Business Strategies

10.28.5 Recent Developments

10.29 S. H. Pitkar Orthotools Pvt. Ltd.

10.29.1 Company Overview

10.29.2 Financial Overview

10.29.3 Product Portfolio

10.29.4 Business Strategies

10.29.5 Recent Developments

10.30 Shenzhen World Surgery Medical Device Technology Co., Ltd

10.30.1 Company Overview

10.30.2 Financial Overview

10.30.3 Product Portfolio

10.30.4 Business Strategies

10.30.5 Recent Developments

10.31 Stryker Corporation

10.31.1 Company Overview

10.31.2 Financial Overview

10.31.3 Product Portfolio

10.31.4 Business Strategies

10.31.5 Recent Developments

10.32 Zimmer Holdings, Inc.

10.32.1 Company Overview

10.32.2 Financial Overview

10.32.3 Product Portfolio

10.32.4 Business Strategies

10.32.5 Recent Developments

 

TABLE 1 Market Snapshot: Global Craniomaxillofacial Implants Market

TABLE 2 Global Craniomaxillofacial Implants Market Revenue, by Location, 2012 – 2022 (USD Million)

TABLE 3 Global Craniomaxillofacial Implants Market Revenue, by Composition, 2012 – 2022 (USD Million)

TABLE 4 Global Craniomaxillofacial Implants Market Revenue, by Nature, 2012 – 2022 (USD Million)

TABLE 5 Global Craniomaxillofacial Implants Market Revenue, by Product, 2012 – 2022 (USD Million)

TABLE 6 Global Craniomaxillofacial Implants Market Revenue, by Geography, 2012 – 2022 (USD Million)

TABLE 7 North America Craniomaxillofacial Implants Market Revenue, by Country, 2012 – 2022 (USD Million)

TABLE 8 Europe Craniomaxillofacial Implants Market Revenue, by Country, 2012 – 2022 (USD Million)

TABLE 9 Asia Pacific Craniomaxillofacial Implants Market Revenue, by Country, 2012 – 2022 (USD Million)

TABLE 10 Latin America Craniomaxillofacial Implants Market Revenue, by Country, 2012 – 2022 (USD Million)

TABLE 11 MENA Craniomaxillofacial Implants Market Revenue, by Country, 2012 – 2022 (USD Million)

 

FIG. 1 Craniomaxillofacial Implants: Market Segmentation

FIG. 2 Global Craniomaxillofacial Implants Market, by Location and Composition, 2013 (USD Million)

FIG. 3 Global Craniomaxillofacial Implants Market, by Nature and Type, 2013 (USD Million)

FIG. 4 Comparative Analysis: Global Craniomaxillofacial Implants Market Revenue, by Geography, 2013 and 2022 (Value %)

FIG. 5 Porter’s Five Forces Analysis: Global Craniomaxillofacial Implants Market

FIG. 6 Value Chain Analysis: Global Craniomaxillofacial Implants Market

FIG. 7 Market Attractiveness Analysis: Global Craniomaxillofacial Implants Market, by Geography (2013)

FIG. 8 Craniomaxillofacial Implants Market Share by Key Players, 2013 (%)

FIG. 9 Global Internal Fixators of Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

FIG. 10 Global External Fixators of Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

FIG. 11 Comparative Analysis: Global Craniomaxillofacial Implants Market, by Composition, 2013 and 2022 (Value %)

FIG. 12 Global Calcium Ceramics Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

FIG. 13 Global Metals and Alloys Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

FIG. 14 Global Polymers Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

FIG. 15 Global Biologic Materials Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

FIG. 16 Global Non-resorbable Fixators in Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

FIG. 17 Global Resorbable Fixators in Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

FIG. 18 Comparative Analysis: Global Craniomaxillofacial Implants Market, by Type, 2013 and 2022 (Value %)

FIG. 19 Global Plate and Screw Fixator Systems in Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

FIG. 20 Global Bone Graft Substitutes in Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

FIG. 21 Global Distraction Systems in Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

FIG. 22 Global TMJ Replacement Devices in Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

FIG. 23 U.S. Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

FIG. 24 Canada Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

FIG. 25 U.K. Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

FIG. 26 Germany Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

FIG. 27 France Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

FIG. 28 Rest of Europe Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

FIG. 29 Japan Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

FIG. 30 China Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

FIG. 31 Rest of Asia Pacific Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

FIG. 32 Brazil Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

FIG. 33 Rest of Latin America Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

FIG. 34 UAE Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

FIG. 35 Rest of MENA Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

FIG. 36 Rest of the World Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

FIG. 37 B. Braun Melsungen AG: Annual Revenue, 2011 - 2013 (USD Million)

FIG. 38 CONMED: Annual Revenue, 2011 – 2013 (USD Million)

FIG. 39 Johnson and Johnson Annual Revenue (USD Million) of Medical Devices Segment, 2012 – 2014

FIG. 40 Integra LifeSciences Corporation: Annual Revenue, 2011 – 2013 (USD Million)

FIG. 41 Medtronic, Inc., Annual Revenue: 2011 – 2013 (USD Million)

FIG. 42 Stryker Corporation: Annual Revenue: 2011 – 2013 (USD Million)

FIG. 43 Zimmer Holdings, Inc. Annual Revenue: 2011 – 2013 (USD Million)